APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Caitlin Cheung und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4, Apolipoproteins E, Hispanic or Latino. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging (NIA).
Abstract (Originalsprache)
BACKGROUND Apolipoprotein E ( APOE ) alleles are well‐established genetic risk factors for Alzheimer's disease (AD), but their effects on AD biomarkers (amyloid beta [Aβ]42/40, phosphorylated tau [p‐tau]181, neurofilament light chain [NfL], and glial fibrillary acidic protein [GFAP]) may vary across populations due to ancestry‐, age‐, and sex‐related differences. We hypothesized that these effects vary across Hispanic/Latino background groups with distinct ancestral admixture. METHODS We analyzed ε2 and ε4 allele associations with AD biomarkers using survey‐weighted linear regression models, adjusting for demographic covariates. Secondary analyses examined genetic analysis group‐ and ancestry‐specific effects. RESULTS ε4 was associated with lower Aβ42/40 and higher p‐tau181and GFAP levels, but not with NfL, suggesting its role in Aβ and tau deposition and neuroinflammation. ε4 associations were stronger in those with higher European and lower African ancestry. DISCUSSION These findings expand on prior studies suggesting that genetic ancestry modifies APOE ‐associated AD risk in Hispanic/Latino populations and highlight the importance of capturing ancestry‐based heterogeneity in AD biomarker research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- CardioVascular Institute (CVI), Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
- Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
- Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Human Genetics Center, Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Förderung
- NIA NIH HHS
- National Institute on Aging (NIA)
Zitieren
APA
Cheung, C., Anita, N. Z., Filigrana, P., Fornage, M., Gonzalez, K. A., Gallo, L. C., Isasi, C. R., Kaplan, R. C., Li, X., Márquez, F., Parada, H., Perreira, K. M., Ramos, A. R., Rundek, T., Tarraf, W., Testai, F. D., DeCarli, C., González, H. M., & Sofer, T. (2026). APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71213
Vancouver
Cheung C, Anita NZ, Filigrana P, Fornage M, Gonzalez KA, Gallo LC, et al. APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71213
BibTeX
@article{Cheung2026,
author = {Cheung, Caitlin and Anita, Natasha Z and Filigrana, Paola and Fornage, Myriam and Gonzalez, Kevin A and Gallo, Linda C and Isasi, Carmen R and Kaplan, Robert C and Li, Xihao and Márquez, Freddie and Parada, Humberto and Perreira, Krista M and Ramos, Alberto R and Rundek, Tatjana and Tarraf, Wassim and Testai, Fernando D and DeCarli, Charles and González, Hector M and Sofer, Tamar},
title = {APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71213}
}
EUVIMED